© 2020 MJH Life Sciences and OncLive. All rights reserved.
June 10th 2020, 1:23am
Benjamin Leon Musher, MD, discusses immunotherapy versus TKIs in hepatocellular carcinoma.
June 9th 2020, 9:46pm
June 4th 2020, 1:53am
Tannaz Armaghany, MD, discusses the utility of circulating tumor DNA in colorectal cancer.
April 4th 2020, 1:44am
Tannaz Armaghany, MD, discusses sorafenib versus lenvatinib as first-line therapy for patients with hepatocellular carcinoma.
March 26th 2020, 2:33am
Tannaz Armaghany, MD, discusses the importance of NCI-MATCH trial in colorectal cancer.
March 9th 2020, 7:51pm
Benjamin Leon Musher, MD, discusses sequencing challenges and research efforts needed regarding immunotherapy in hepatocellular carcinoma before it becomes a standard approach for patients.
February 18th 2020, 2:51am
Investigators are exploring concurrent PARP inhibition and definitive regional radiotherapy in patients with metastatic invasive cervical cancer in an ongoing phase I/II study.
November 12th 2019, 8:50pm
Ghanshyam Yadav, MD, discusses the differences between type 1 and type 2 uterine cancer.
August 28th 2019, 12:36am
The group of researchers is conducting the largest African-American prostate cancer study ever, aiming to include 10,000 men nationwide.
August 26th 2019, 10:09pm
Baylor College of Medicine has been awarded more than $17.4 million by the Cancer Prevention & Research Institute of Texas to support new cancer research and programs, core facilities and recruitment of new faculty.